The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Effect of Aspirin on Disability-free Survival in the Healthy Elderly
Open accessAbstract
BACKGROUND: Information on the use of aspirin to increase healthy independent life span in older persons is limited. Whether 5 years of daily low-dose aspirin therapy would extend disability-free life in healthy seniors is unclear. METHODS: From 2010 through 2014, we enrolled community-dwelling persons in Australia and the United States who were 70 years of age or older (or ≥65 years of age among blacks and Hispanics in the United States) and did not have cardiovascular disease, dementia, or physical disability. Participants were randomly assigned to receive 100 mg per day of enteric-coated aspirin or placebo orally. The primary end point was a composite of death, dementia, or persistent physical disability. Secondary end points reported in this article included the individual components of the primary end point and major hemorrhage. RESULTS: A total of 19,114 persons with a median age of 74 years were enrolled, of whom 9525 were randomly assigned to receive aspirin and 9589 to receive placebo. A total of 56.4% of the participants were women, 8.7% were nonwhite, and 11.0% reported previous regular aspirin use. The trial was terminated at a median of 4.7 years of follow-up after a determination was made that there would be no benefit with continued aspirin use with regard to the primary end point. The rate of the composite of death, dementia, or persistent physical disability was 21.5 events per 1000 person-years in the aspirin group and 21.2 per 1000 person-years in the placebo group (hazard ratio, 1.01; 95% confidence interval [CI], 0.92 to 1.11; P=0.79). The rate of adherence to the assigned intervention was 62.1% in the aspirin group and 64.1% in the placebo group in the final year of trial participation. Differences between the aspirin group and the placebo group were not substantial with regard to the secondary individual end points of death from any cause (12.7 events per 1000 person-years in the aspirin group and 11.1 events per 1000 person-years in the placebo group), dementia, or persistent physical disability. The rate of major hemorrhage was higher in the aspirin group than in the placebo group (3.8% vs. 2.8%; hazard ratio, 1.38; 95% CI, 1.18 to 1.62; P<0.001). CONCLUSIONS: Aspirin use in healthy elderly persons did not prolong disability-free survival over a period of 5 years but led to a higher rate of major hemorrhage than placebo. (Funded by the National Institute on Aging and others; ASPREE ClinicalTrials.gov number, NCT01038583 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One RCT found 100 mg aspirin versus placebo in 19 114 healthy adults older than 65 years did not reduce dementia (HR 1·0, 95% CI 0·8–1·2), death, physical disability, or cardiovascular disease over a period of 4·7 years.”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [87]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Katz, S. (1983) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1983.tb03391.x · Cited by 2,734
(1987) · PubMed · Cited by 2,657
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Randomised trial of prophylactic daily aspirin in British male doctors
Peto, R., Gray, R. G., Collins, R., Wheatley, K., Hennekens, C. H., Jamrozik, K. D., Warlow, C., Hafner, B., Thompson, E., Norton, S., et al. (1988) · BMJ · doi:10.1136/bmj.296.6618.313 · Cited by 1,164
Carnethon, M. R., Pu, J., Howard, G., Albert, M. A., Anderson, C. A. M., Bertoni, A. G., Mujahid, M. S., Palaniappan, L., Taylor, H. A., Willis, M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000534 · Cited by 1,147
Research works printed but not linked: 2
- Whitlock EP Williams SB Burda BU Feightner A Beil T. Aspirin use in adults: cancer all-cause mortality and harms: a systematic evidence review for the U.S. Preventive Services Task Force. Evidence syntheses no. 132. Rockville MD: Agency for Healthcare Research and Quality 2015 (https://www.ncbi.nlm.nih.gov/books/NBK321643/).
- Diagnostic and statistical manual of mental disorders, 4th ed.: DSM IV. Washington, DC: American Psychiatric Association, 1994.
Cited by
Sorted by citations
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430
RetractedBy the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15767 · Cited by 3,163
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly
McNeil, J. J., Wolfe, R., Woods, R. L., Tonkin, A. M., Donnan, G. A., Nelson, M. R., Reid, C. M., Lockery, J. E., Kirpach, B., Storey, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805819 · Cited by 1,139
Self-citationEffect of Aspirin on All-Cause Mortality in the Healthy Elderly
McNeil, J. J., Nelson, M. R., Woods, R. L., Lockery, J. E., Wolfe, R. S., Reid, C. M., Kirpach, B., Shah, R. C., Ives, D. G., Storey, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1803955 · Cited by 837
Self-citationThe quest to slow ageing through drug discovery
Partridge, L., Fuentealba, M., & Kennedy, B. K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0067-7 · Cited by 468
Burn, J., Sheth, H. J., Elliott, F., Reed, L., Macrae, F., Mecklin, J., Möslein, G., McRonald, F. E., Bertario, L., Evans, D. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30366-4 · Cited by 435
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O. C., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 432
Ten things to know about ten cardiovascular disease risk factors
Bays, H. E., Taub, P. R., Epstein, E., Michos, E. D., Ferraro, R. A., Bailey, A. L., Kelli, H. M., Ferdinand, K. C., Echols, M. R., Weintraub, H., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100149 · Cited by 274
Role of AMPK mediated pathways in autophagy and aging
Ge, Y., Zhou, M., Chen, C., Wu, X., & Wang, X. (2021) · Biochimie · doi:10.1016/j.biochi.2021.11.008 · Cited by 261
Dementia Prevention and Treatment
Reuben, D. B., Kremen, S. A., & Maust, D. T. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.8522 · Cited by 225
Cainzos-Achirica, M., Miedema, M. D., McEvoy, J. W., Al Rifai, M., Greenland, P., Dardari, Z., Budoff, M., Blumenthal, R. S., Yeboah, J., Duprez, D. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045010 · Cited by 201
Hodis, H. N., & Mack, W. J. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000591 · Cited by 211
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline
Ryan, J. L., Storey, E., Murray, A. M., Woods, R. L., Wolfe, R. S., Reid, C. M., Nelson, M. R., Chong, T. T. ‐., Williamson, J. D., Ward, S. A., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009277 · Cited by 184
Self-citationThe rise and fall of aspirin in the primary prevention of cardiovascular disease
Raber, I., McCarthy, C. P., Vaduganathan, M., Bhatt, D. L., Wood, D. A., Cleland, J. G. F., Blumenthal, R. S., & McEvoy, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30541-0 · Cited by 175
Freak‐Poli, R., Ryan, J. L., Neumann, F., Tonkin, A. M., Reid, C. M., Woods, R. L., Nelson, M. R., Stocks, N. P., Berk, M., McNeil, J. J., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02602-2 · Cited by 194
Self-citationESO Guideline on covert cerebral small vessel disease
Wardlaw, J. M., Debette, S., Jokinen, H., de Leeuw, F., Pantoni, L., Chabriat, H., Staals, J., Doubal, F., Rudilosso, S., Eppinger, S., et al. (2021) · European Stroke Journal · doi:10.1177/23969873211012132 · Cited by 178
RetractedAspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer
Guirguis‐Blake, J., Evans, C. V., Perdue, L. A., Bean, S., & Senger, C. A. (2022) · JAMA · doi:10.1001/jama.2022.3337 · Cited by 169
Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes
Lacaze, P. A., Bakshi, A., Riaz, M., Polekhina, G., Owen, A. J., Bhatia, H. S., Natarajan, P., Wolfe, R. S., Beilin, L. J., Nicholls, S. J., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.07.027 · Cited by 164
Self-citationRole of aspirin in primary prevention of cardiovascular disease
Patrono, C., & Baigent, C. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0225-y · Cited by 163
Is Alzheimer’s Disease Risk Modifiable?
Serrano‐Pozo, A., & Growdon, J. H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad181028 · Cited by 168
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults
McNeil, J. J., Gibbs, P., Orchard, S. G., Lockery, J. E., Bernstein, W. B., Cao, Y., Ford, L. G., Haydon, A. M., Kirpach, B., Macrae, F., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa114 · Cited by 154
Self-citation(2022) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezag193 · Cited by 146
Ten things to know about ten cardiovascular disease risk factors – 2022
Bays, H. E., Agarwala, A., German, C. A., Satish, P., Iluyomade, A., Dudum, R., Thakkar, A., Rifai, M. A., Mehta, A., Thobani, A., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100342 · Cited by 148
Aspirin and antiplatelet treatments in cancer
Tao, D. L., Yunga, S. T., Williams, C. D., & McCarty, O. J. T. (2021) · Blood · doi:10.1182/blood.2019003977 · Cited by 124
Effect of Statin Therapy on Cognitive Decline and Incident Dementia in Older Adults
Zhou, Z., Ryan, J. L., Ernst, M. E., Zoungas, S., Tonkin, A. M., Woods, R. L., McNeil, J. J., Reid, C. M., Curtis, A. J., Wolfe, R. S., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.075 · Cited by 112
Self-citationCardiac Contributions to Brain Health: A Scientific Statement From the American Heart Association
Testai, F. D., Gorelick, P. B., Chuang, P., Dai, X., Furie, K. L., Gottesman, R. F., Iturrizaga, J. C., Lazar, R. M., Russo, A. M., Seshadri, S. S., et al. (2024) · Stroke · doi:10.1161/str.0000000000000476 · Cited by 106
O'Brien, C. W., Juraschek, S. P., & Wee, C. C. (2019) · Annals of Internal Medicine · doi:10.7326/m19-0953 · Cited by 100
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease
Patrono, C. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae324 · Cited by 110
Joyce, J., Ryan, J. L., Owen, A. J., Hu, J., Power, J. M., Shah, R. C., Woods, R. L., Storey, E., Britt, C. J., Freak‐Poli, R., et al. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5644 · Cited by 103
Self-citationMohebbi, M., Agustini, B., Woods, R. L., McNeil, J. J., Nelson, M. R., Shah, R. C., Nguyen, V. N. B., Storey, E., Murray, A. M., Reid, C. M., et al. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5119 · Cited by 100
Self-citationErnst, M. E., Broder, J. C., Wolfe, R. S., Woods, R. L., Nelson, M. R., Ryan, J. L., Shah, R. C., Orchard, S. G., Chan, A. T., Espinoza, S. E., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107231 · Cited by 94
Self-citationBerk, M., Woods, R. L., Nelson, M. R., Shah, R. C., Reid, C. M., Storey, E., Fitzgerald, S., Lockery, J. E., Wolfe, R., Mohebbi, M., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.1214 · Cited by 89
Self-citationShould Aspirin Be Used for Primary Prevention in the Post-Statin Era?
Ridker, P. M. (2018) · New England Journal of Medicine · doi:10.1056/nejme1812000 · Cited by 91
Joseph, J., Pajewski, N. M., Dolor, R. J., Sellers, M. A., Perdue, L., Peeples, S. R., Henrie, A. M., Woolard, N., Jones, W. S., Benziger, C. P., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18312 · Cited by 91
Self-citationCohort Profile: The ASPREE Longitudinal Study of Older Persons (ALSOP)
McNeil, J. J., Woods, R. L., Ward, S. A., Britt, C. J., Lockery, J. E., Beilin, L. J., & Owen, A. J. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy279 · Cited by 85
Self-citationAntiaging effects of bioactive molecules isolated from plants and fungi
Martel, J., Ojcius, D. M., Ko, Y., Chang, C., & Young, J. D. (2019) · Medicinal Research Reviews · doi:10.1002/med.21559 · Cited by 79
Eisen, D. P., Leder, K. S., Woods, R. L., Lockery, J. E., McGuinness, S. L., Wolfe, R. S., Pilcher, D. V., Moore, E., Shastry, A. M., Nelson, M. R., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30411-2 · Cited by 82
Self-citationInflammation-Accelerated Senescence and the Cardiovascular System: Mechanisms and Perspectives
Pinto, R. D., & Ferri, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123701 · Cited by 77
Zoungas, S., Curtis, A. J., Spark, S., Wolfe, R. S., McNeil, J. J., Beilin, L. J., Chong, T. T. ‐., CLOUD, G. C., Hopper, I., Kost, A., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069915 · Cited by 80
Self-citationHu, J., Fitzgerald, S. M., Owen, A. J., Ryan, J. L., Joyce, J., Chowdhury, E., Reid, C. M., Britt, C. J., Woods, R. L., McNeil, J. J., et al. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5601 · Cited by 71
Self-citationTrajectories of depressive symptoms in older adults and associated health outcomes
Agustini, B., Lotfaliany, M., Mohebbi, M., Woods, R. L., McNeil, J. J., Nelson, M. R., Shah, R. C., Murray, A. M., Reid, C. M., Tonkin, A. M., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00203-1 · Cited by 75
Self-citationGao, X., Coull, B. A., Lin, X., Vokonas, P., Spiro, A., Hou, L., Schwartz, J. D., & Baccarelli, A. (2021) · Nature Aging · doi:10.1038/s43587-021-00060-4 · Cited by 67
Zhou, Z., Ofori‐Asenso, R., Curtis, A. J., Breslin, M. C., Wolfe, R. S., McNeil, J. J., Murray, A. M., Ernst, M. E., Reid, C. M., Lockery, J. E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.016 · Cited by 65
Self-citationLow-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People
CLOUD, G. C., Williamson, J. D., Thảo, L. T. P., Tran, C., Eaton, C. B., Wolfe, R. S., Nelson, M. R., Reid, C. M., Newman, A. B., Lockery, J. E., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.25803 · Cited by 65
Self-citationColey, N., Giulioli, C., Aisen, P. S., Vellas, B., & Andrieu, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101777 · Cited by 62
Miura, S., Naito, T., Mitsunaga, S., Omae, K., Mori, K. P., Inano, T., Yamaguchi, T., Tatematsu, N., Okayama, T., Morikawa, A., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5762-6 · Cited by 60
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults
Zhou, Z., Ryan, J. L., Tonkin, A. M., Zoungas, S., Lacaze, P. A., Wolfe, R. S., Orchard, S. G., Murray, A. M., McNeil, J. J., Yu, C., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207923 · Cited by 62
Self-citationStructural modification of aspirin to design a new potential cyclooxygenase (COX-2) inhibitors
Uzzaman, M., & Mahmud, T. (2020) · In Silico Pharmacology · doi:10.1007/s40203-020-0053-0 · Cited by 59
Long‐Term Blood Pressure Variability and Risk of Cognitive Decline and Dementia Among Older Adults
Ernst, M. E., Ryan, J., Chowdhury, E. K., Margolis, K. L., Beilin, L. J., Reid, C. M., Nelson, M. R., Woods, R. L., Shah, R. C., Orchard, S. G., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019613 · Cited by 55
Self-citationBeyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer
Zhang, X., Feng, Y., Liu, X., Ma, J., Li, Y., Wang, T., & Li, X. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-02902-6 · Cited by 58
Ryan, J. L., Woods, R. L., Britt, C. J., Murray, A. M., Shah, R. C., Reid, C. M., Wolfe, R. S., Nelson, M. R., Orchard, S. G., Lockery, J. E., et al. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200194 · Cited by 55
Self-citationRyan, J. L., Espinoza, S. E., Ernst, M. E., Ekram, A. S., Wolfe, R. S., Murray, A. M., Shah, R. C., Orchard, S. G., Fitzgerald, S. M., Beilin, L. J., et al. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab225 · Cited by 56
Self-citationRyan, J. L., Woods, R. L., Murray, A. M., Shah, R. C., Britt, C. J., Reid, C. M., Wolfe, R. S., Nelson, M. R., Lockery, J. E., Orchard, S. G., et al. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1730444 · Cited by 55
Self-citationAntithrombotic Management of Elderly Patients With Coronary Artery Disease
Capranzano, P., & Angiolillo, D. J. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.01.040 · Cited by 53
Manchikanti, L. (2019) · Pain Physician · doi:10.36076/ppj/2019.22.s75 · Cited by 62
Endpoints for geroscience clinical trials: health outcomes, biomarkers, and biologic age
Cummings, S. R., & Kritchevsky, S. B. (2022) · GeroScience · doi:10.1007/s11357-022-00671-8 · Cited by 54
Biology of frailty: Implications for clinical pharmacology and drug therapy in frail older people
Hilmer, S. N., Wu, H. C., & Zhang, M. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111119 · Cited by 58
Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
Badria, F. A.-E. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.83082 · Cited by 53
Cardiovascular risk prediction in healthy older people
Neumann, F., Thảo, L. T. P., Callander, E. J., Chowdhury, E., Williamson, J. D., Nelson, M. R., Donnan, G. A., Woods, R. L., Reid, C. M., Poppe, K., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00486-z · Cited by 55
Self-citationHussain, S. M., Robb, C. E., Tonkin, A. M., Lacaze, P. A., Chong, T. T. ‐., Beilin, L. J., Yu, C., Watts, G. F., Ryan, J. L., Ernst, M. E., et al. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100963 · Cited by 50
Self-citationErnst, M. E., Chowdhury, E., Beilin, L. J., Margolis, K. L., Nelson, M. R., Wolfe, R. S., Tonkin, A. M., Ryan, J. L., Woods, R. L., McNeil, J. J., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.16209 · Cited by 49
Self-citationPham, T., McNeil, J. J., Barker, A. L., Orchard, S. G., Newman, A. B., Robb, C. E., Ernst, M. E., Espinoza, S. E., Woods, R. L., Nelson, M. R., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0285530 · Cited by 48
Self-citationRevisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease
Marquis‐Gravel, G., Roe, M. T., Harrington, R. A., Muñoz, D., Hernandez, A. F., & Jones, W. S. (2019) · Circulation · doi:10.1161/circulationaha.119.040205 · Cited by 48
Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies
Zaman, F. Y., Orchard, S. G., Haydon, A. M., & Zalcberg, J. R. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01882-8 · Cited by 47
Self-citationRiaz, M., Huq, A. J., Ryan, J. L., Orchard, S. G., Tiller, J. M., Lockery, J. E., Woods, R. L., Wolfe, R. S., Renton, A. E., Goate, A., et al. (2021) · Aging Cell · doi:10.1111/acel.13384 · Cited by 44
Self-citationLockery, J. E., Collyer, T. A., Abhayaratna, W. P., Fitzgerald, S. M., McNeil, J. J., Nelson, M. R., Orchard, S. G., Reid, C. M., Stocks, N., Trevaks, R. E., et al. (2018) · The Medical Journal of Australia · doi:10.5694/mja2.12060 · Cited by 44
Self-citationFeng, M., Kim, J., Field, K. P., Reid, C., Chatzistamou, I., & Shim, M. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00041 · Cited by 44
Self-citationUpper Gastrointestinal Bleeding
Costable, N. J., & Greenwald, D. A. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.09.001 · Cited by 43
Loomans-Kropp, H. A., Pinsky, P. F., Cao, Y., Chan, A. T., & Umar, A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.16729 · Cited by 42
Bainey, K. R., Marquis‐Gravel, G., Belley‐Côté, E. P., Turgeon, R. D., Ackman, M. L., Babadagli, H. E., Bewick, D. J., Boivin‐Proulx, L., Cantor, W. J., Fremes, S. E., et al. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.10.013 · Cited by 46
Smith, E. E., Barber, P. A., Field, T. S., Ganesh, A., Hachinski, V., Hogan, D. B., Lanctôt, K. L., Lindsay, M. P., Sharma, M., Swartz, R. H., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12056 · Cited by 41
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
Parish, S., Mafham, M., Offer, A., Barton, J., Wallendszus, K., Stevens, W., Buck, G., Haynes, R., Collins, R., Bowman, L., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac179 · Cited by 40
Antiplatelet and Anticoagulant Therapy in Interventional Pain Management
Manchikanti, L., Sanapati, M. R., Kaye, A. D., & Kaye, A. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-46217-7_7 · Cited by 40
Aspirin in the Prevention of Cardiovascular Disease and Cancer
Ricciotti, E., & FitzGerald, G. A. (2021) · Annual Review of Medicine · doi:10.1146/annurev-med-051019-102940 · Cited by 41
Neumann, F., Riaz, M., Bakshi, A., Polekhina, G., Thảo, L. T. P., Nelson, M. R., Woods, R. L., Abraham, G., Inouye, M., Reid, C. M., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.033670 · Cited by 39
Self-citationEspinoza, S. E., Woods, R. L., Ekram, A. R. M. S., Ernst, M. E., Polekhina, G., Wolfe, R., Shah, R. C., Ward, S. A., Storey, E., Nelson, M. R., et al. (2022) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glab340 · Cited by 39
Self-citationCombination of gait speed and grip strength to predict cognitive decline and dementia
Orchard, S. G., Polekhina, G., Ryan, J. L., Shah, R. C., Storey, E., Chong, T. T. ‐., Lockery, J. E., Ward, S. A., Wolfe, R. S., Nelson, M. R., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12353 · Cited by 43
Self-citationRenda, G., Patti, G., Lang, I. M., Siller-Matula, J. M., Hylek, E. M., Ambrosio, G., Haas, S. K., & Caterina, R. D. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.004 · Cited by 39
Calderone, D., Greco, A., Ingala, S., Agnello, F. G., Franchina, A. G., Scalia, L., Buccheri, S., & Capodanno, D. (2021) · Thrombosis and Haemostasis · doi:10.1055/a-1667-7427 · Cited by 37
The year in cardiology 2018: prevention
Reiner, Ž., Laufs, U., Cosentino, F., & Landmesser, U. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy894 · Cited by 37
Hongo, T., Yamamoto, R., Liu, K., Yaguchi, T., Dote, H., Saito, R., Masuyama, T., Nakatsuka, K., Watanabe, S., Kanaya, T., et al. (2022) · Critical Care · doi:10.1186/s13054-022-03974-6 · Cited by 36
Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly
McQuilten, Z., Thảo, L. T. P., Pasricha, S., Artz, A. S., Bailey, M., Chan, A. T., Cohen, H. J., Lockery, J. E., Murray, A. M., Nelson, M. R., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0675 · Cited by 36
Self-citationNeumann, F., Thảo, L. T. P., Callander, E. J., Carr, P. R., Qaderi, V., Nelson, M. R., Reid, C. M., Woods, R. L., Orchard, S. G., Wolfe, R. S., et al. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00308-1 · Cited by 39
Self-citationPrediction of disability-free survival in healthy older people
Neumann, F., Thảo, L. T. P., Murray, A. M., Callander, E. J., Carr, P. R., Nelson, M. R., Wolfe, R. S., Woods, R. L., Reid, C. M., Shah, R. C., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00547-x · Cited by 39
Self-citationThe Impact of Cognitive Impairment on Cardiovascular Disease
Jamil, Y., Krishnaswami, A., Orkaby, A. R., Stimmel, M. B., Brown, C. H., Mecca, A. P., Forman, D. E., Rich, M. W., Nanna, M. G., & Damluji, A. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.057 · Cited by 39
The ASPREE Healthy Ageing Biobank: Methodology and participant characteristics
Parker, E. J., Orchard, S. G., Gilbert, T., Phung, J., Owen, A. J., Lockett, T. J., Nelson, M. R., Reid, C. M., Tonkin, A. M., Abhayaratna, W. P., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0294743 · Cited by 35
Self-citationAspirin Protects Melanocytes and Keratinocytes against UVB-Induced DNA Damage In Vivo
Rahman, H., Kumar, D., Liu, T., Okwundu, N., Lum, D. H., Florell, S. R., Burd, C. E., Boucher, K. M., VanBrocklin, M. W., & Grossman, D. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.06.003 · Cited by 33
ESO Guideline on covert cerebral small vessel disease
Wardlaw, J. M., Debette, S., Jokinen, H., de Leeuw, F., Pantoni, L., Chabriat, H., Staals, J., Doubal, F., Rudilosso, S., Eppinger, S., et al. (2021) · European Stroke Journal · doi:10.1177/23969873211027002 · Cited by 33
RetractedEvaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
Naito, T. (2019) · Asia-Pacific Journal of Oncology Nursing · doi:10.4103/apjon.apjon_68_18 · Cited by 33
Mielke, N., Huscher, D., Douros, A., Ebert, N., Gaedeke, J., van der Giet, M., Kuhlmann, M. K., Martus, P., & Schäeffner, E. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-1430-6 · Cited by 34
Wang, Y., Han, S., Qin, H., Zheng, H., Jiang, B., Cao, Y., Gao, Y., Guan, L., Jia, Q., Jiang, Y., et al. (2020) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000385 · Cited by 32
How I treat anemia in older adults
Oyedeji, C. I., Artz, A. S., & Cohen, H. J. (2023) · Blood · doi:10.1182/blood.2022017626 · Cited by 34
Acute Myocardial Infarction and Risk of Cognitive Impairment and Dementia: A Review
Thong, E. H., Quek, J. W. E., Loo, J. H., Yun, C.-Y., Teo, Y. N., Teo, Y. H., Leow, A. S., Li, T. Y., Sharma, V. K., Tan, B. Y., et al. (2023) · Biology · doi:10.3390/biology12081154 · Cited by 31
Rhee, T. G., Kumar, M., Ross, J. S., & Coll, P. P. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17038 · Cited by 33
A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults
Lockery, J. E., Broder, J. C., Ryan, J. L., Stewart, A. C., Woods, R. L., Chong, T. T. ‐., CLOUD, G. C., Murray, A. M., Rigby, J., Shah, R. C., et al. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06550-2 · Cited by 33
Self-citationAngiolillo, D. J., & Capodanno, D. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.12.022 · Cited by 29
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease
Mann, J. F. E., Joseph, P., Gao, P., Pais, P., Tyrwhitt, J., Xavier, D., Dans, T., López-Jaramillo, P. A., Gamra, H., & Yusuf, S. (2022) · Kidney International · doi:10.1016/j.kint.2022.09.023 · Cited by 31
Wolfe, R. S., Wetmore, J. B., Woods, R. L., McNeil, J. J., Gallagher, H., Roderick, P. J., Walker, R. G., Nelson, M. R., Reid, C. M., Shah, R. C., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.08.011 · Cited by 29
Self-citationAdvances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies
Grory, B. M., Yaghi, S. R., Cordonnier, C., Sposato, L. A., Romano, J. G., & Chaturvedi, S. (2022) · Circulation Research · doi:10.1161/circresaha.121.319947 · Cited by 29
Cyclooxygenase Inhibitors and Cancer: The Missing Pieces
Patrono, C. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001631 · Cited by 29
Metadata
- Authors
- McNeil, J. J., Woods, R. L., Nelson, M. R., Reid, C. M., Kirpach, B., Wolfe, R., Storey, E., Shah, R. C., Lockery, J. E., Tonkin, A. M., Newman, A. B., Williamson, J. D., Margolis, K. L., Ernst, M. E., Abhayaratna, W. P., Stocks, N., Fitzgerald, S. M., Orchard, S. G., Trevaks, R. E., Beilin, L. J., Donnan, G. A., Gibbs, P., Johnston, C. I., Ryan, J., Radziszewska, B., Grimm, R., & Murray, A. M.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- University of Tasmania (AU)
- Rush University Medical Center (US)
- University of Iowa (US)
- Australian National University (AU)
- National Institutes of Health (US)
- University of Minnesota (US)
- ORCID
- McNeil, John J.
- Woods, Robyn L.
- Nelson, Mark R.
- Reid, Christopher M.
- Kirpach, Brenda
- Wolfe, Rory
- Storey, Elsdon
- Shah, Raj C.
- Lockery, Jessica E.
- Tonkin, Andrew M.
- Newman, Anne B.
- Williamson, Jeff D.
- Margolis, Karen L.
- Ernst, Michael E.
- Abhayaratna, Walter P.
- Stocks, Nigel
- Fitzgerald, Sharyn M.
- Orchard, Suzanne G.
- Trevaks, Ruth E.
- Beilin, Lawrence J.
- Donnan, Geoffrey A.
- Gibbs, Peter
- Ryan, Joanne
- Murray, Anne M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-10-18
- Volume
- 379
- Issue
- 16
- Pages
- 1499-1508
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6426126
- OpenAlex
- W2891412296
- Cited by
- 590
- References
- 35
- Citations by year
- 2026: 44 · 2025: 69 · 2024: 64 · 2023: 85 · 2022: 67 · 2021: 91 · 2020: 72 · 2019: 79 · 2018: 19
- FWCI
- 49.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- UTAS Research Repository (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- eSpace (Curtin University) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- Victorian Cancer Agency, Australia
- National Health and Medical Research Council of Australia (334047, 1127060)
- Monash University, Australia
- National Institutes of Health (U01AG029824)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
- Keywords
- aspirin, healthy older adults, disability-free survival, dementia, physical disability, mortality, major bleeding, bleeding risk, community-dwelling older adults, trial termination, medication adherence, enteric-coated aspirin, cardiovascular disease prevention, cognitive function
- MeSH terms
- Administration, Oral, Aged, Aged, 80 and over, Aspirin, Australia, Dementia, Double-Blind Method, Female, Follow-Up Studies, Persons with Disabilities, Disabled Persons, Hemorrhage, Humans, Male, Mortality, Platelet Aggregation Inhibitors, United States, Incidence, Treatment Failure, Disease-Free Survival, Independent Living
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
